education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Thailand
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Thailand
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Chlovas
Chlovas
atorvastatin
Manufacturer:
Millimed
Distributor:
Millimed
Concise Prescribing Info
Contents
Atorvastatin Ca
Indications/Uses
Treatment of dyslipidemia & heterozygous familial hypercholesterolemia. Primary & secondary prevention of CV disease. Reduce the risk of fatal CHD & non-fatal MI, stroke, angina pectoris.
Dosage/Direction for Use
10-80 mg once daily. Starting & maintenance dose individualized according to baseline LDL-cholesterol levels, goal of therapy & patient response.
Administration
May be taken with or without food: Avoid excessive consumption (>1 L/day) of grapefruit juice.
Contraindications
Liver disease, unexplained & persistent elevation in LFTs, skeletal muscle disease. Pregnancy & lactation.
Special Precautions
Regularly perform LFT. Monitor CPK levels. History of liver disease. Avoid alcohol consumption.
Adverse Reactions
Constipation, flatulence, abdominal pain, headache, nausea, myalgia, muscle spasms, joint swelling, diarrhea, increased blood creatinine phosphokinase.
View
ADR Monitoring Form
Drug Interactions
Increased risk of myopathy w/ cyclosporin, fibric acid derivatives or CYP450 3A4 inhibitors. Increase plasma conc of digoxin. Decreased plasma conc w/ antacids containing Mg & Al.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Thai FDA Category
D
Presentation/Packing
Form
Chlovas tab 40 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in